190 related articles for article (PubMed ID: 22432556)
21. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
[TBL] [Abstract][Full Text] [Related]
22. Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesity.
Baessler A; Strack C; Rousseva E; Wagner F; Bruxmeier J; Schmiedel M; Riegger G; Lahmann C; Loew T; Schmitz G; Fischer M
Eur J Heart Fail; 2012 Nov; 14(11):1240-8. PubMed ID: 22843563
[TBL] [Abstract][Full Text] [Related]
23. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
[TBL] [Abstract][Full Text] [Related]
24. Influence of renal impairment on myocardial function in outpatients with systolic heart failure: an echocardiographic and cardiac biomarker study.
Bosselmann H; Tonder N; Sölétormos G; Rossing K; Iversen K; Goetze JP; Gustafsson F; Schou M
Int J Cardiol; 2014 Dec; 177(3):942-8. PubMed ID: 25449505
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
[TBL] [Abstract][Full Text] [Related]
26. NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure.
Vergaro G; Januzzi JL; Cohen Solal A; Aimo A; Arzilli C; Zyw L; Valleggi A; Giannoni A; Prontera C; Barison A; Poletti R; Gabutti A; Mammini C; Passino C; Emdin M
Int J Cardiol; 2018 Nov; 271():324-330. PubMed ID: 30223365
[TBL] [Abstract][Full Text] [Related]
27. [Asymptomatic ischemic heart dysfunction, echocardiographic changes and NT-proBNP during 2-years observation].
Skrzypek A; Nessler J
Przegl Lek; 2014; 71(7):378-83. PubMed ID: 25338333
[TBL] [Abstract][Full Text] [Related]
28. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
[TBL] [Abstract][Full Text] [Related]
29. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
30. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
Motoki H; Borowski AG; Shrestha K; Troughton RW; Tang WH; Thomas JD; Klein AL
J Am Coll Cardiol; 2012 Nov; 60(20):2074-81. PubMed ID: 23083779
[TBL] [Abstract][Full Text] [Related]
31. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
[TBL] [Abstract][Full Text] [Related]
32. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP
J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185
[TBL] [Abstract][Full Text] [Related]
33. Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study.
Weiner RB; Baggish AL; Chen-Tournoux A; Marshall JE; Gaggin HK; Bhardwaj A; Mohammed AA; Rehman SU; Barajas L; Barajas J; Gregory SA; Moore SA; Semigran MJ; Januzzi JL
Eur J Heart Fail; 2013 Mar; 15(3):342-51. PubMed ID: 23132825
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
35. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
[TBL] [Abstract][Full Text] [Related]
36. [The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].
Tuğcu A; Yildirimtürk O; Aytekin S
Turk Kardiyol Dern Ars; 2009 Mar; 37(2):112-21. PubMed ID: 19404033
[TBL] [Abstract][Full Text] [Related]
37. IVC diameter in patients with chronic heart failure: relationships and prognostic significance.
Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG
JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557
[TBL] [Abstract][Full Text] [Related]
38. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
[TBL] [Abstract][Full Text] [Related]
39. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
40. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
